Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-year repeat-dose Fluenz immunogenicity and safety study in children
ISRCTN11725083Phase 4Completed
- Sponsor
- Health Protection Agency
- Start
- Sep 2014
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, open-label, single-arm trial of live attenuated influenza vaccine in influenza, sponsored by Health Protection Agency. Primary endpoint: Geometric mean titre. Started Sep 2014; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on ISRCTN11725083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11725083.